How Tentarix's US$35m capital raise is set to boost business for Vancouver's ITS

📆 07-09-23 03:45:00
📰 PGCitizen

⏱ Reading Time:
30 sec. here
2 min. at publisher
📊 Quality Score:
News: 15%
Publisher: 51%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Vancouver's Innovative Targeting Solutions partners with San-Diego-based Tentarix to make drugs

San Diego-based Tentarix Biotherapeutics' US$35-million Series B financing is good news for Vancouver's Innovative Targetting Solutions , with which it shares executives and co-founders.

ITS employs 14 staff who work out of the company's 5,000-square-foot head office and lab on Virtual Way in East Vancouver. ITS is not hiring at the moment, Kang said, but he does expect the company's workload to expand. Tentarix today announced that its new US$35-million financing was led by Amplitude Ventures with participation from Gilead Sciences, Inc. , and founding investors Versant Ventures and Samsara BioCapital.

Tentarix in 2021 raised US$50 million in a financing round co-led by two San Francisco-based companies: Versant and Samsara BioCapital.

Écrire un Commentaire

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

How Tentarix's US$35m capital raise is set to boost business for Vancouver's ITSVancouver's Innovative Targeting Solutions partners with San-Diego-based Tentarix to make drugs
La source: BurnabyNOW_News - 🏆 14. / 77 Lire la suite »